| Dr Richard K Choi, D O | |
|
4755 Ogletown Stanton Rd, Section Of Neurosciences, Suite 1e90, Newark, DE 19718-2200 | |
| (302) 733-5982 | |
| (302) 733-6081 |
| Full Name | Dr Richard K Choi |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 16 Years |
| Location | 4755 Ogletown Stanton Rd, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639308067 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
"Gov. Arnold Schwarzenegger replaced most members of the state Board of Registered Nursing on Monday, citing the unacceptable time it takes to discipline nurses accused of egregious misconduct," The Los Angeles Times reports.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679727028 PECOS PAC ID: 9739097569 Enrollment ID: O20090306000025 |
News Archive
Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
"Gov. Arnold Schwarzenegger replaced most members of the state Board of Registered Nursing on Monday, citing the unacceptable time it takes to discipline nurses accused of egregious misconduct," The Los Angeles Times reports.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457593949 PECOS PAC ID: 9739097569 Enrollment ID: O20090715000610 |
News Archive
Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
"Gov. Arnold Schwarzenegger replaced most members of the state Board of Registered Nursing on Monday, citing the unacceptable time it takes to discipline nurses accused of egregious misconduct," The Los Angeles Times reports.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245474329 PECOS PAC ID: 9739097569 Enrollment ID: O20091027000729 |
News Archive
Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
"Gov. Arnold Schwarzenegger replaced most members of the state Board of Registered Nursing on Monday, citing the unacceptable time it takes to discipline nurses accused of egregious misconduct," The Los Angeles Times reports.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard K Choi, D O 200 Hygeia Drive, Suite 2300, Newark, DE 19713 Ph: (215) 349-8466 | Dr Richard K Choi, D O 4755 Ogletown Stanton Rd, Section Of Neurosciences, Suite 1e90, Newark, DE 19718-2200 Ph: (302) 733-5982 |
News Archive
Further underscoring its ongoing commitment to lung health, Covidien today unveiled a next-generation version of its superDimension™ Navigation System software. The updated software features a more intuitive interface that helps reduce time spent by physicians planning the procedure and enhances the visualization of the airways of the lung.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
"Gov. Arnold Schwarzenegger replaced most members of the state Board of Registered Nursing on Monday, citing the unacceptable time it takes to discipline nurses accused of egregious misconduct," The Los Angeles Times reports.
Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 3 days ago
Jonathan M Raser-schramm, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-733-1888 | |
Dr. Ayesha Silman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Yawar Abbas, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Rockford Center, 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Dr. Panna Kalyanji Jolapara, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18 Capano Drive, Apt C4, Newark, DE 19702 Phone: 302-292-8693 Fax: 302-292-8693 | |
Enrica Arnaudo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 | |
Stephen Doyle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 | |
Lanny Edelsohn, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 |